PH25190A - Method for reducing reperfusion injury with imidazol-2-thiones - Google Patents

Method for reducing reperfusion injury with imidazol-2-thiones

Info

Publication number
PH25190A
PH25190A PH36651A PH36651A PH25190A PH 25190 A PH25190 A PH 25190A PH 36651 A PH36651 A PH 36651A PH 36651 A PH36651 A PH 36651A PH 25190 A PH25190 A PH 25190A
Authority
PH
Philippines
Prior art keywords
thiones
imidazol
reperfusion injury
reducing reperfusion
reducing
Prior art date
Application number
PH36651A
Other languages
English (en)
Inventor
Richard C Dage
Richard A Schnettler
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of PH25190A publication Critical patent/PH25190A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PH36651A 1987-03-20 1988-03-17 Method for reducing reperfusion injury with imidazol-2-thiones PH25190A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2851687A 1987-03-20 1987-03-20

Publications (1)

Publication Number Publication Date
PH25190A true PH25190A (en) 1991-03-27

Family

ID=21843888

Family Applications (1)

Application Number Title Priority Date Filing Date
PH36651A PH25190A (en) 1987-03-20 1988-03-17 Method for reducing reperfusion injury with imidazol-2-thiones

Country Status (7)

Country Link
EP (1) EP0284925A3 (fr)
JP (1) JPS63258418A (fr)
KR (1) KR880010771A (fr)
AU (1) AU605559B2 (fr)
DK (1) DK151588A (fr)
PH (1) PH25190A (fr)
ZA (1) ZA881807B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7141597B2 (en) * 2003-09-12 2006-11-28 Allergan, Inc. Nonsedating α-2 agonists

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4405628A (en) * 1981-03-05 1983-09-20 Merrell Dow Pharmaceuticals Inc. 4-Pyridylimidazolones and method of use
NZ202351A (en) * 1981-11-04 1986-02-21 Merrell Dow Pharma Imidazole carboxamines
US4552880A (en) * 1983-02-15 1985-11-12 Merrell Dow Pharmaceuticals Inc. Aroylimidazolones
ZA887662B (en) * 1987-10-19 1989-06-28 Merrell Dow Pharma Method for reducing reperfusion injury with imidazol-2-thione-carboxamides

Also Published As

Publication number Publication date
JPS63258418A (ja) 1988-10-25
EP0284925A3 (fr) 1990-06-13
DK151588D0 (da) 1988-03-18
ZA881807B (en) 1988-09-05
AU1315988A (en) 1988-09-22
EP0284925A2 (fr) 1988-10-05
DK151588A (da) 1988-09-21
AU605559B2 (en) 1991-01-17
KR880010771A (ko) 1988-10-24

Similar Documents

Publication Publication Date Title
GB2213416B (en) Blade-carriers for retractable-blade knives
YU128488A (en) Process and device for injecting
GB8710687D0 (en) Cutting apparatus
EP0308288A3 (en) Flotation apparatus
JPS6434293A (en) Fermentation method
EP0280567A3 (en) Means for electrophoresis
AR244495A1 (es) Metodo para fumigar productos agricolas en medios de transporte o almacenamiento y catalizador solido utilizado en dicho metodo.
IL88321A0 (en) Sialocylglycerolipids and method for preparing same
GB8724209D0 (en) Moulding method
ZA887662B (en) Method for reducing reperfusion injury with imidazol-2-thione-carboxamides
GB8713205D0 (en) Grinding method
PH25190A (en) Method for reducing reperfusion injury with imidazol-2-thiones
GB2202788B (en) Cutting apparatus
IE883147L (en) Method for reducing reperfusion injury
PH25234A (en) Expression method
EP0281305A3 (en) Method for preparing aminohydrocarbyl-substituted ketoximosilanes
GB2202493B (en) Curve drawing apparatus
GB8716315D0 (en) Moulding method
GB2206837B (en) Method for moulding
YU149786A (en) Process for alkylizing izoparaffin with olephinic agents
BG43457A1 (en) Method for preparing means with fungicide action
IE880626L (en) Method for reducing neurotoxic injury
PL264543A1 (en) Method for deriving chlornitromenzene
GB8708887D0 (en) Sawing method
GB8615199D0 (en) Vehicle retrieval apparatus